Organovo and Samsara Sciences Partner with New Manufacturing USA Institute
The Advanced Regenerative Manufacturing Institute (ARMI) will receive nearly $300 million in public-private investment from leading manufacturers, universities, nonprofit organizations and the federal government to develop scalable manufacturing processes for engineered tissues and organs.
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions
Samsara Sciences entered a non-exclusive global supply agreement with Lonza Bioscience Solutions. Under the terms of the agreement, Lonza will market human cell products from Samsara for further distribution to its customers.